A detailed history of Zacks Investment Management transactions in Johnson & Johnson stock. As of the latest transaction made, Zacks Investment Management holds 956,443 shares of JNJ stock, worth $139 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
956,443
Previous 863,857 10.72%
Holding current value
$139 Million
Previous $126 Million 22.76%
% of portfolio
1.36%
Previous 1.42%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $13.5 Million - $15.5 Million
92,586 Added 10.72%
956,443 $155 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $4.73 Million - $5.16 Million
32,735 Added 3.94%
863,857 $126 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $6.25 Million - $6.55 Million
40,235 Added 5.09%
831,122 $131 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $6.71 Million - $7.32 Million
-46,053 Reduced 5.5%
790,887 $124 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $426,443 - $477,726
-2,738 Reduced 0.33%
836,940 $130 Million
Q2 2023

Aug 15, 2023

BUY
$154.35 - $166.11 $9.24 Million - $9.94 Million
59,859 Added 7.68%
839,678 $139 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $7.35 Million - $7.91 Million
-47,646 Reduced 5.76%
779,819 $129 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $6.54 Million - $7.81 Million
43,319 Added 5.52%
827,465 $128 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $4.73 Million - $5.3 Million
29,495 Added 3.91%
784,146 $139 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $2.52 Million - $2.81 Million
15,638 Added 2.12%
754,651 $123 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $7.45 Million - $8.24 Million
44,291 Added 6.38%
739,013 $131 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $4.98 Million - $5.65 Million
31,483 Added 4.75%
694,722 $123 Million
Q4 2021

Feb 15, 2022

BUY
$155.93 - $173.01 $1.85 Million - $2.05 Million
11,838 Added 1.82%
663,239 $113 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $2.77 Million - $3.08 Million
17,168 Added 2.71%
651,401 $105 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $5.13 Million - $5.5 Million
32,149 Added 5.34%
634,233 $104 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $8.62 Million - $9.6 Million
-56,288 Reduced 8.55%
602,084 $99 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $2.46 Million - $2.82 Million
-17,927 Reduced 2.65%
658,372 $104 Million
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $3.49 Million - $3.82 Million
24,864 Added 3.82%
676,299 $101 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $3.35 Million - $4.05 Million
-26,039 Reduced 3.84%
651,435 $91.6 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $4.35 Million - $6.03 Million
39,170 Added 6.14%
677,474 $88.8 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $25,755 - $29,580
202 Added 0.03%
638,304 $93.1 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $1.83 Million - $2.05 Million
14,404 Added 2.31%
638,102 $82.6 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $846,835 - $931,357
6,457 Added 1.05%
623,698 $86.9 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $3.45 Million - $3.83 Million
-27,416 Reduced 4.25%
617,241 $86.3 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $3.9 Million - $4.7 Million
-31,788 Reduced 4.7%
644,657 $83.2 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $179,695 - $211,176
1,478 Added 0.22%
676,445 $93.5 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $480,107 - $529,806
4,021 Added 0.6%
674,967 $81.9 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $718,324 - $850,619
5,742 Added 0.86%
670,946 $86 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $1.27 Million - $1.39 Million
9,676 Added 1.48%
665,204 $92.9 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $84.9 Million - $88.7 Million
655,528
655,528 $85.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.